Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...
Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, today announced the full commercial launch of its EpiPlexâ„¢ platform, the first to concurrently detect and quantify multiple RNA ...
Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, today announced the full commercial launch of its EpiPlextm platform, the first to concurrently detect and quantify multiple ...
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
The Protein Sequencing Companytm, announces the formation of its Scientific Advisory Board. Comprised of distinguished experts in proteomics, genomics, bioinformatics, chemistry, ...
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation ...
By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.
A study reveals DNA and RNA epigenetics work together as a complementary system for precise gene regulation, crucial for cell ...
nucleic acids (including DNA and RNA), proteins, lipids and glycans. From the construction, modification and interaction of these components, the cell develops and functions. The struggle to ...
A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.
SMi’s 11 th annual RNA Therapeutics conference, taking place on 19 th – 20 th February in London, will bring together industry experts from leading RNA therapeutics companies to discuss the ...